Arrhythmia Clinical Trial
Official title:
The Effect of General Anesthesia on the Risk for Arrhythmia -A Pilot Study
Polymorphic ventricular tachycardia, known as Torsades de Pointes (TdP), is a specific form
of ventricular arrhythmia with a characteristic twist of the QRS complex around the
isoelectric baseline. TdP can degenerate into ventricular defibrillation followed by sudden
cardiac death. A predictor for the development of TdP is the length of the QT interval
measured on an EKG recording. The QT interval is known to be prolonged by many medications
used in a perioperative setting as well as by other conditions such as hypothermia and
electrolyte imbalance. General anesthesia exposes most of the investigators patients to a
combination of several of those medications and conditions and therefore might increase the
risk for the development of QT prolongation. Moreover, patient related risk factors are well
known and aggravate the individual risk for potential life threatening TdP events when
exposed to QT prolonging medications perioperatively.
Previous research suggests that more than 20% of the patients might develop QT prolongations
perioperatively and are consequently on an increased risk for TdP; yet, no study has
systematically investigated the magnitude of the problem and associated risk factors.
The proposed pilot study is designed as a prospective observational cohort study to
investigate the QT interval before, during and after general anesthesia. It aims to
determine the incidence of perioperative QT prolongations. A customary long term EKG
recording device will be connected to a random sample of patients undergoing general
anesthesia. Using these continuous EKG tracings, the lengths of the QT interval will be
analyzed during the perioperative period.
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05048602 -
Drug-induced Brugada Syndrome Research Database
|
||
Completed |
NCT05053243 -
Clinical Validation of the AliveCor Kardia 12L and 6L Devices
|
N/A | |
Completed |
NCT01913561 -
The Use of Master Caution Garment for Continuous Monitoring for Arrhythmia Detection
|
N/A | |
Completed |
NCT01688648 -
Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft
|
N/A | |
Completed |
NCT01396226 -
A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients
|
Phase 2 | |
Terminated |
NCT00624520 -
Mental Stress Reduction in Defibrillator Patients
|
Phase 3 | |
Completed |
NCT00756886 -
Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study
|
N/A | |
Terminated |
NCT00721149 -
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study
|
Phase 3 | |
Completed |
NCT00510029 -
Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously
|
Phase 1 | |
Completed |
NCT00578617 -
Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial
|
N/A | |
Active, not recruiting |
NCT00135174 -
Cost-Effectiveness of Routine Follow-up Visits in Patients With a Pacemaker: The Followpace Study
|
N/A | |
Completed |
NCT00119847 -
Electrophysiological Effects of Late PCI After MI
|
N/A | |
Completed |
NCT00023556 -
Genetic Architecture of Heart Disease in Rural Brazil
|
N/A | |
Completed |
NCT00035490 -
Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
|
Phase 3 | |
Completed |
NCT00004560 -
Public Access Defibrillation (PAD) Community Trial
|
Phase 3 | |
Completed |
NCT01076361 -
Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study
|
N/A | |
Recruiting |
NCT00138931 -
Genetics of Cardiovascular and Neuromuscular Disease
|
||
Completed |
NCT00622453 -
Arrhythmias in Myotonic Muscular Dystrophy
|
N/A | |
Completed |
NCT01076348 -
Model 4965 Post-Approval Study
|
||
Completed |
NCT00000531 -
Antiarrhythmics Versus Implantable Defibrillators (AVID)
|
Phase 3 |